An at-risk group points to the possibility that the condition may be associated with the risk of vital nutrient (micronutrient) deficiency.
The complaint chronic fatigue syndrome indicates a vital substance (micronutrient) deficiency for:
- Folic acid
In the context of vital substance deficiencies (micronutrients), the following vital substances (macro- and micronutrients) are used for supportive therapy:
- Omega-3 fatty acids docohexaenoic acid and eicosapentaenoic acid.
- Omega-6 fatty acids gamma-linolenic acid and linoleic acid
- Coenzyme Q10
- L-Carnitine
The above vital substance recommendations (micronutrients) were created with the help of medical experts. All statements are supported by scientific studies with high levels of evidence. For a therapy recommendation, only clinical studies with the highest degrees of evidence (grade 1a/1b and 2a/2b) were used, which due to their high significance prove the therapy recommendation. These data are updated at certain intervals.
* Vital substances (macro- and micronutrients) include vitamins, minerals, trace elements, vital amino acids, vital fatty acids, etc.
